THERACHON
Therachon is a global biotechnology company focused on developing medicines for rare, genetic diseases that currently have no available treatments. The company’s lead pipeline candidate, TA-46, is a novel protein therapy in development for achondroplasia, the most common form of short-limbed dwarfism. Therachon is headquartered in Basel, Switzerland, with research labs in Nice, France.
THERACHON
Industry:
Biotechnology Medical Therapeutics
Founded:
2014-01-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.therachon.com
Total Employee:
11+
Status:
Closed
Contact:
+41798989209
Email Addresses:
[email protected]
Total Funding:
100 M USD
Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Dyn DNS Dyn Hosting
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-10-09 | GLyPharma Therapeutic | GLyPharma Therapeutic acquired by Therachon | N/A |
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Series B - Therachon
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series B - Therachon
Bpifrance
Bpifrance investment in Series B - Therachon
Versant Ventures
Versant Ventures investment in Series B - Therachon
Cowen Healthcare Investments
Cowen Healthcare Investments investment in Series B - Therachon
OrbiMed
OrbiMed investment in Series B - Therachon
Tekla Capital Management
Tekla Capital Management investment in Series B - Therachon
Novo Holdings
Novo Holdings investment in Series B - Therachon
Inserm Transfert Initiative
Inserm Transfert Initiative investment in Series A - Therachon
OrbiMed
OrbiMed investment in Series A - Therachon
Official Site Inspections
http://www.therachon.com
- Host name: 192.29.61.237
- IP address: 192.29.61.237
- Location: Zurich Switzerland
- Latitude: 47.4049
- Longitude: 8.4631
- Timezone: Europe/Zurich
- Postal: 8102
